CLINICAL_TRIALS ClinicalTrials.gov record update

Addition of Pembrolizumab Upon Progression on Enzalutamide in Men With mCRPC

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02312557
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:54.024462+00:00
Published At: 2025-01-20T00:00:00+00:00
Record Updated At: 2025-12-03
Results Posted At: 2025-01-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Castration-Resistant Prostate Carcinoma", "Hormone-Resistant Prostate Cancer", "PSA Progression", "Recurrent Prostate Carcinoma", "Stage IV Prostate Adenocarcinoma Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-12-03"
protocolSection.identificationModule.nctId: "NCT02312557"
protocolSection.identificationModule.officialTitle: "Addition of Pembrolizumab Upon Progression on Enzalutamide in Men With mCRPC"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-01-20"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.